Skip to search formSkip to main contentSkip to account menu

S 18326

Known as: S-18326 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Boron CompoundsOligopeptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Dose-effect relationship for several coagulation markers during administration of the direct thrombin inhibitor S 18326 in healthy subjects.
AIMS We conducted a phase I placebo-controlled trial with two i.v. doses (0.5 mg h-1 and 3 mg h-1) of S 18326, a selective… 
1999
1999
S 18326: a thrombin inhibitor that shows potential for oral treatment of thromboembolic disorders.
Antivitamin K agents are currently the only orally available anticoagulant compounds. During the past two decades, important… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)